HIGH LEVELS OF ERCC1 ARE ASSOCIATED WITH CISPLATIN RESISTANCE IN NEUROBLASTOMA

被引：0
|
作者：
Meret, Henry [1 ]
Wang, Zhihong [1 ]
Liu, Yimin [1 ]
机构：
[1] Childrens Hosp Michigan, Detroit, MI 48201 USA
来源：
PEDIATRIC BLOOD & CANCER | 2011年 / 57卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：784 / 784
页数：1
相关论文
共 50 条
  • [31] ERCC1 and lung cancer
    Planchard, D.
    Olaussen, K. -A.
    Soria, J. -C.
    REVUE DES MALADIES RESPIRATOIRES, 2010, 27 (04) : 387 - 394
  • [32] The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients
    Obiedat, Hadeel
    Alrabadi, Nasr
    Sultan, Eyad
    Al Shatti, Marwa
    Zihlif, Malek
    BMC MEDICAL GENETICS, 2018, 19
  • [33] mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines
    Shimizu, Junichi
    Horio, Yoshitsugu
    Osada, Hirotaka
    Hida, Toyoaki
    Hasegawa, Yoshinori
    Shimokata, Kaoru
    Takahashi, Takashi
    Sekido, Yoshitaka
    Yatabe, Yasushi
    RESPIROLOGY, 2008, 13 (04) : 510 - 517
  • [34] Lentivirus-Mediated RNAi Silencing Targeting ERCC1 Reverses Cisplatin Resistance in Cisplatin-Resistant Ovarian Carcinoma Cell Line
    Du, Pei
    Zhang, Xiaowei
    Liu, Hualin
    Chen, Liquan
    DNA AND CELL BIOLOGY, 2015, 34 (07) : 497 - 502
  • [35] Functional Polymorphisms at ERCC1/XPF Genes Confer Neuroblastoma Risk in Chinese Children
    Zhuo, Zhen-Jian
    Liu, Wei
    Zhang, Jiao
    Zhu, Jinhong
    Zhang, Ruizhong
    Tang, Jue
    Yang, Tianyou
    Zou, Yan
    He, Jing
    Xia, Huimin
    EBIOMEDICINE, 2018, 30 : 113 - 119
  • [36] Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome
    Huang, Ming-Yii
    Wang, Jaw-Yuan
    Huang, Meng-Lin
    Chang, Hui-Jen
    Lin, Shiu-Ru
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (02): : 4121 - 4134
  • [37] ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer
    Kim, Min Kyoung
    Cho, Kyung-Ja
    Kwon, Gui Young
    Park, Seung-Il
    Kim, Yong Hee
    Kim, Jong Hoon
    Song, Ho-Young
    Shin, Ji Hoon
    Jun, Hwoon Yong
    Lee, Gin Hyug
    Choi, Kee Don
    Kim, Sung-Bae
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (01) : 54 - 60
  • [38] Upregulation of ZNRD1 enhances cisplatin resistance in human esophageal cancer cells by regulation of ERCC1 and bcl-2
    Guo, Wei
    Zhao, Yun-Ping
    Jiang, Yao-Guang
    Wang, Ru-Wen
    Hong, Liu
    Fan, Dai-Ming
    TUMOR BIOLOGY, 2008, 29 (03) : 188 - 194
  • [39] ERCC1 Expression and Outcomes in Head and Neck Cancer Treated with Concurrent Cisplatin and Radiation
    Hayes, Mose
    Lan, Cynthia
    Yan, Jingsheng
    Xie, Yang
    Gray, Toby
    Amirkhan, Robin H.
    Dowell, Jonathan E.
    ANTICANCER RESEARCH, 2011, 31 (12) : 4135 - 4139
  • [40] Characterization of monoclonal antibody recognizing ERCC1 overexpression, a potential biomarker for cisplatin response
    Oishi, Takayuki
    Sasaki, Yuka
    Tong, Ying
    Chen Lichao
    Onodera, Takae
    Iwasa, Satoru
    Udo, Emiko
    Furusato, Bungo
    Nakao, Kazuhiko
    Yamada, Yasuhide
    Hiraoka, Nobuyoshi
    Masutani, Mitsuko
    CANCER SCIENCE, 2021, 112 : 915 - 915
12345